浙农股份(002758) - 2015 Q2 - 季度财报

Financial Performance - The company's operating revenue for the first half of 2015 was ¥578,604,301.32, representing a 5.17% increase compared to ¥550,148,820.19 in the same period last year[21]. - The net profit attributable to shareholders was ¥20,234,810.39, up 12.79% from ¥17,939,862.07 year-on-year[21]. - The net profit after deducting non-recurring gains and losses was ¥19,821,236.69, reflecting a 12.98% increase from ¥17,544,012.03 in the previous year[21]. - Operating profit reached ¥26,620,695.10, reflecting a year-on-year growth of 12.89%[31]. - The basic earnings per share increased to ¥0.46, a 6.98% rise from ¥0.43 in the same period last year[21]. - The company reported a comprehensive income for the period amounting to CNY 20,234,810.39, indicating a significant increase compared to the previous period's comprehensive income[146]. - The total comprehensive income for the period was 35,018,508.24 yuan, reflecting a significant increase compared to the previous period[155]. Assets and Liabilities - The company's total assets increased by 20.81% to ¥914,490,469.89 from ¥756,986,158.08 at the end of the previous year[21]. - The total assets of the company increased to CNY 807,089,147.48 from CNY 606,091,405.01, reflecting a growth of 33.2%[131]. - Total liabilities decreased to CNY 410,905,327.89 from CNY 477,812,626.47, a reduction of approximately 14%[123]. - The company's equity increased significantly to CNY 503,585,142.00, up from CNY 279,173,531.61, indicating an increase of about 80.5%[124]. - The total liabilities decreased to CNY 355,648,067.28 from CNY 376,570,546.57, a reduction of approximately 5.5%[131]. - The company reported a decrease in short-term borrowings from CNY 128,000,000.00 to CNY 73,000,000.00, a decline of 43%[123]. Cash Flow - The net cash flow from operating activities was negative at -¥37,494,705.53, a decline of 148.50% compared to -¥15,088,464.29 in the previous year[21]. - Cash inflow from financing activities totaled ¥298,335,290.57, significantly up from ¥53,000,000.00 in the previous period[140]. - The net increase in cash and cash equivalents was ¥102,032,497.95, compared to a decrease of -¥53,748,557.44 in the prior period[140]. - Total cash and cash equivalents at the end of the period reached ¥236,368,411.76, up from ¥64,616,224.58[140]. Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for this period[7]. - The company distributed a cash dividend of 4.00 CNY per 10 shares, totaling 16.8 million CNY based on a total share capital of 42 million CNY as of the end of 2014[61]. - The company raised 1,400,000 shares at an issuance price of 18.04 yuan per share, increasing the total share capital to 56,000,000 shares[157]. - The largest shareholder, Zhejiang Shaoxing Huatuo Trading Group Co., Ltd., holds 26.25% of the shares[107]. Investments and Projects - The company has invested CNY 3.69889 million in the traditional Chinese medicine processing project, achieving 36.99% of the planned investment[59]. - The company has not made any external investments, held financial enterprise equity, or engaged in securities investments during the reporting period[42][43][44][45][46]. - The company has not reported any changes in the projects funded by raised funds during the reporting period[53]. Corporate Governance and Compliance - The company maintained compliance with corporate governance regulations and improved its internal management systems[68]. - The company has not engaged in any major litigation or arbitration matters during the reporting period[69]. - The company has not faced any penalties or rectification issues during the reporting period[96]. Financial Reporting - The semi-annual financial report has not been audited[95]. - The company has established a comprehensive financial reporting framework in accordance with the relevant accounting standards and regulations[159]. - The company adheres to the enterprise accounting standards, ensuring that the financial statements accurately reflect its financial position, operating results, and cash flows for the reporting period[162].